Research Article

Cluster-Randomized Controlled Study of SMS Text Messages for Prevention of Mother-to-Child Transmission of HIV in Rural Kenya

Table 2

Antiretroviral usage among study participants.

Intervention ControlAdjusted effect estimates
Difference [95% CIRelative risk [95% CI]

Antiretroviral usage outcomes at 34–36 weeksN = 261N = 242
Mother taking any type of antiretrovirals 254 (97.3%)241 (99.6%)0.40% [−1.9, 2.7]1.04 [0.91, 1.18]
Mother on combination antiretroviral therapy 51 (20.1%)51 (21.2%)−0.10% [−4.9, 4.7]1.01 [0.29, 3.45]
Any missed doses in the past week19 (7.5%)13 (5.4%)0.20% [−1.1, 1.6]1.25 [0.43, 3.6]
Outcomes at delivery, 7 days postpartumN = 247N = 229
Mother taking any type of antiretrovirals 234 (94.7%)229 (100%)−0.10% [−2.6, 2.3]1.01 [0.88, 1.16]
Mother on combination antiretroviral therapy 59 (25.2%)50 (21.8%)0.70% [−4.3, 5.8]1.28 [0.36, 4.62]
Any maternal missed doses in past week18 (7.8%)12 (5.3%)0.40% [−1.3, 2.1]1.56 [0.43, 5.61]
Infant started taking antiretrovirals199 (80.9%)209 (90.1%)−1.20% [−4.8, 2.4]0.91 [0.77, 1.14]
Outcomes 6–8 weeks postpartum
N = 244N = 227
Mother taking any type of antiretrovirals178 (73%)200 (88.1%)−2.10% [−7.3, 3.1]0.87 [0.61, 1.24]
Mother on combination antiretroviral therapy 49 (27.5%)52 (26%)−0.20% [−4.9, 4.6]0.92 [0.28, 3.09]
Any maternal missed doses in the past week19 (10.7%)7 (3.5%)0.80% [−1.1, 2.8]2.09 [0.37, 11.77]

on cluster residuals.